ArticleFrontiers in cell and developmental biology2021

Cabozantinib Reverses Topotecan Resistance in Human Non-Small Cell Lung Cancer NCI-H460/TPT10 Cell Line and Tumor Xenograft Model.

Zi-Ning Lei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.